Wikidata entity: Q65472044
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 49 |
| P6099 | clinical trial phase | ... | Q5452194 (phase I clinical trial) | phase I clinical trial |
| P6099 | clinical trial phase | ... | Q42824440 (phase II clinical trial) | phase II clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2012-02-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P4844 | research intervention | ... | Q419940 (dasatinib) | dasatinib |
| P6153 | research site | ... | Q131252 (University of Chicago) | University of Chicago |
| P6153 | research site | ... | Q168751 (Duke University) | Duke University |
| P6153 | research site | ... | Q7896459 (University of Texas at Houston Police Department) | University of Texas at Houston Police Department |
| P859 | sponsor | ... | Q266423 (Bristol-Myers Squibb) | Bristol-Myers Squibb |
| P580 | start time | ... | 2007-07-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | Phase I/II Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer | ??? |
| P3098 | ClinicalTrials.gov ID | NCT00439270 |
Why not click here or view trends?
log id: 5046736